A Retrospective Analysis of Pembrolizumab With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer: Experience From a Tertiary Care Hospital
The data suggest that pembrolizumab, with or without chemotherapy, is an effective and safe treatment option for advanced NSCLC in Indian patients, particularly in resource-constrained settings. Further prospective studies are warranted to confirm these findings.
Authors
- Jhuma Das (ORCID: https://orcid.org/0000-0003-3548-3105)
- Parag Roy (ORCID: https://orcid.org/0000-0002-8300-3148)
- Rajan Yadav (ORCID: https://orcid.org/0000-0002-1551-8414)
Institutions
- Gujarat Cancer & Research Institute (IN)
- Netaji Subhash Chandra Bose Medical College (IN)
- Tata Main Hospital (IN)
- B.J. Medical College (IN)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-03
- DOI
- https://doi.org/10.7759/cureus.78459
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00